Picture of PROCEPT BioRobotics logo

PRCT — PROCEPT BioRobotics News Story

0.000.00%
us flag iconLast trade - 00:00
HealthcareAdventurousMid CapFalling Star

Procept Biorobotics Corp reports results for the quarter ended in December - Earnings Summary

* Procept Biorobotics Corp  PRCT.OQ  reported a quarterly
adjusted
loss of 54 cents​​ per share for the quarter ended in December,
higher than the same quarter last year, when the company
reported EPS of -56 cents.  The mean expectation of
eight analysts for the quarter was for a loss of 44 cents per
share. Wall Street expected results to range from -50 cents
to -40 cents per share.
    * Revenue rose 83.3% to $43.58 million from a year ago;
analysts
expected $42.06 million. 
    * Procept Biorobotics Corp's reported EPS for the quarter
was a
loss of 54 cents​.
    * The company reported a quarterly loss of $27.5 million.
    * Procept Biorobotics Corp shares had risen by 16.5% this
quarter.

FORECAST CHANGES
    * The mean earnings estimate of analysts had fallen by
about 1.4%
in the last three months.​ 
    * In the last 30 days, there have been no earnings estimate
revisions by analysts covering the company.

RECOMMENDATIONS
    * The current average analyst rating on the shares is "buy"
and
the breakdown of recommendations is 8 "strong buy" or "buy," 1
"hold" and no "sell" or "strong sell." 
    * Wall Street's median 12-month price target for Procept
Biorobotics Corp is $50.00 

This summary was machine generated from LSEG data February 27 at
11:36 p.m. UTC. ​All figures in US dollars unless otherwise
stated. (For questions concerning the data in this report,
contact Estimates.Support@lseg.com. For any other questions or
feedback, contact RefinitivNewsSupport@thomsonreuters.com) QUARTER ENDING    ESTIMATE       ACTUAL         BEAT, MET,
                                                 MISSED
 Dec. 31 2023      -0.44          -0.54          Missed
 Sep. 30 2023      -0.51          -0.51          Met
 Jun. 30 2023      -0.57          -0.56          Beat
 Mar. 31 2023      -0.58          -0.63          Missed

Recent news on PROCEPT BioRobotics

See all news